Pharmafile Logo
Pharmafocus logo
Advanced Search

PXV Funds

Showing 1 posts of 1 posts found.

Lexeo Therapeutics, PXV Funds and venBio launch new entity to advance RNA therapies for cardiac diseases

June 27, 2025
Mergers and Acquisitions, Research and Development Cardiology, Lexeo Therapeutics, PXV Funds, RNA-based therapies, cardiac genetic medicine, venBio Partners

Lexeo Therapeutics has announced a strategic partnership with life sciences investors Perceptive Xontogeny Venture Funds (PXV Funds) and venBio Partners …

News
The Gateway to Local Adoption Series

Latest content

Long-acting therapies set to reshape HIV treatment market

August 21, 2026

MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy

August 21, 2026

MHRA approves Romvimza for tenosynovial giant cell tumour

August 20, 2026

NICE recommends allergy immunotherapy tablets for younger children

August 19, 2026

Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement

August 18, 2026